KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,740,509 | -28.0% | 365,134 | -7.7% | 0.02% | -22.7% |
| Q2 2023 | $85,776,535 | +41.8% | 395,557 | +18.8% | 0.02% | +29.4% |
| Q1 2023 | $60,477,947 | +1.4% | 332,955 | +9.7% | 0.02% | 0.0% |
| Q4 2022 | $59,637,949 | -13.6% | 303,501 | -1.1% | 0.02% | -22.7% |
| Q3 2022 | $69,029,000 | +4083.6% | 306,895 | +2253.3% | 0.02% | – |
| Q2 2022 | $1,650,000 | +7.0% | 13,041 | +7.2% | 0.00% | – |
| Q1 2022 | $1,542,000 | +0.6% | 12,163 | +4.0% | 0.00% | – |
| Q4 2021 | $1,533,000 | -0.5% | 11,696 | -7.1% | 0.00% | – |
| Q3 2021 | $1,540,000 | +22.9% | 12,585 | +14.5% | 0.00% | – |
| Q2 2021 | $1,253,000 | +73.3% | 10,990 | +82.8% | 0.00% | – |
| Q1 2021 | $723,000 | +120.4% | 6,012 | +86.0% | 0.00% | – |
| Q4 2020 | $328,000 | -97.4% | 3,232 | -97.1% | 0.00% | -100.0% |
| Q2 2020 | $12,413,000 | – | 111,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |